Newsroom Stories

In a new study, WashU Medicine researchers show that vagus nerve stimulation provides substantial, long-lasting relief to some people with the most severe treatment-resistant depression.

In 2025, the WashU community made new discoveries, celebrated new victories and launched new efforts to make the globe safer and healthier. 

A team of WashU researchers has integrated two novel vision-language models that create a potential AI assistant that may help people with cognitive decline cook meals and remain independent.

Faculty experts in political science, history and law at Washington University in St. Louis discuss the recent capture of the Venezuelan president and offer context about President Donald Trump’s latest challenges to international order.

The unfolding crisis in Venezuela, as well as President Trump’s subsequent threats to countries including Greenland, Colombia, Mexico and Iran, threaten international relations and embolden adversaries. David Carter, an expert in international relations and territorial conflict at Washington University in St. Louis, explains why.

Researchers at WashU Medicine and their collaborators have created an immune cell atlas of multiple myeloma, a cancer of the bone marrow. The new resource could improve prognosis and guide development of new immunotherapies.

A team led by Yan Yu of Washington University in St. Louis developed a double-pronged approach to fighting antibiotic resistance.

Historically, public opinion has constrained presidents’ use of unilateral power. But political scientist Dino P. Christenson, at Washington University in St. Louis, explains why public opposition to President Trump’s actions in Venezuela is unlikely to sway him.

Under international law, one of the clearest red lines for states is the use of force to take another sovereign’s territory — a prohibition that sits at the heart of the modern global legal order, says MJ Durkee, a Washington University in St. Louis law professor.

Startups built on WashU discoveries attracted a record $1.7 billion in private-sector investment over the past year, accelerating the commercialization of WashU innovations into life-changing diagnostics, therapeutics and medical devices.